DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/4vp7c7/north_america) has announced the addition of the "North America Feed Antibiotics market - Growth, Trends And Forecasts (2015-2020)" report to their offering.
The North American Feed antibiotics market is $761.3 million in 2015 and is expected to reach a value $849.3 million by 2020 with a CAGR of 2.2%.
Feed antibiotics which have playing the major role in North America because the meat production industry have witnessed a slow down due to rising consumer awareness regarding hazards of residue in the meat. These are important ingredients that are combined with basic feed mix to prevent animal diseases and improve their overall growth. All these benefits of antibiotics have driven the growth of the market in the region.
But the recent developments suggesting that some bacteria have become resistant to more than one type of antibiotic, which makes it more difficult to treat the infections they cause has led to the ban of certain substances in few markets. This has called for the judicious use of antibiotics and in expert recommended quantities to preserve their effectiveness for better human and animal health.
North America is the second largest market in the Feed Antibiotics market.
Key Topics Covered:
2. Key Findings of the Study
3. Market Overview
4. Market Segmentation
5. Competitive Landscape - Feed Additives
6. Company Profiles
- Abbott Laboratories
Bayer HealthCare AG
- Bristol-Myers Squibb Co.
Cubist Pharmaceuticals, Inc.
Daiichi Sankyo Company, Limited
Eli Lilly and Co.
- GlaxoSmithKline Plc
Johnson & Johnson
LG Life Sciences Limited
- Sanofi-Aventis SA
Takeda Pharmaceutical Company, Ltd.
For more information visit http://www.researchandmarkets.com/research/4vp7c7/north_america